Association between epidermal growth factor polymorphism and esophageal squamous cell carcinoma susceptibility

Digestive Diseases and Sciences

Volumn 55, Issue 1, 2010, Pages 40-45

  Cui, Lin ^a   Pan, Xin Min ^b   Ma, Chun Fen ^c   Shang Guan, Jun ^d   Yu, Hai Bin ^a   Chen, Guang Xue ^e   Wang, Jia ^f  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

^d Jiangxi Provincial Center for Disease Control and Prevention   (China)

^e People's Hospital of Daye City   (China)

^f Yan'an Hospital   (China)

Author keywords

Epidermal growth factor (EGF); Esophageal squamous cell carcinoma (ESCC); Single nucleotide polymorphism

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADULT; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA SEQUENCE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENOTYPE; GROUPS BY AGE; HOMOZYGOTE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; WILD TYPE; ESOPHAGUS TUMOR; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; EPIDERMAL GROWTH FACTOR; ESOPHAGEAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 74049083254     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0700-5     Document Type: Article

References (44)

1. XN Zou PR Taylor SD Mark A Chao W Wang SM Dawsey YP Wu YL Qiao SF Zheng 2002 Seasonal variation of food consumption and selected nutrient intake in Linxian, a high-risk area for esophageal cancer in China Int J Vitam Nutr Res 72 375 382 10.1024/0300-9831.72.6.375 10.1024/0300-9831.72.6.375 1:CAS:528:DC%2BD3sXhsFGmu7Y%3D 12596503
2. JF Liu QZ Wang J Hou 2004 Surgical treatment for cancer of the oesophagus and gastric cardia in Hebei, China Br J Surg 91 90 98 10.1002/bjs.4402 10.1002/bjs.4402 1:STN:280:DC%2BD2c%2FhvVWhtA%3D%3D 14716801 (Pubitemid 38122057)
3. G Launoy CH Milan J Faivre P Pienkowski CI Milan M Gignoux 1997 Alcohol, tobacco and oesophageal cancer: effects of the duration of consumption, mean intake and current and former consumption Br J Cancer 75 1389 1396 1:STN:280:DyaK2s3pvF2itA%3D%3D 9155065
4. Y Yokokawa S Ohta J Hou XL Zhang SS Li YM Ping T Nakajima 1999 Ecological study on the risks of esophageal cancer in Ci-Xian, China: the importance of nutritional status and the use of well water Int J Cancer 83 620 624 10.1002/(SICI)1097-0215(19991126)83:5<620::AID-IJC9>3.0.CO;2-W 10.1002/(SICI)1097-0215(19991126)83:5<620::AID-IJC9>3.0.CO;2-W 1:STN:280:DyaK1Mvlt1yqtg%3D%3D 10521797 (Pubitemid 29508040)
5. CS Yang 2000 Vitamin nutrition and gastroesophageal cancer J Nutr 130 338S 339S 1:CAS:528:DC%2BD3cXhtVSls7o%3D 10721901
6. T Matsha R Erasmus AB Kafuko D Mugwanya A Stepien MI Parker 2002 Human papillomavirus associated with oesophageal cancer J Clin Pathol 55 587 590 10.1136/jcp.55.8.587 10.1136/jcp.55.8.587 1:STN:280:DC%2BD38zpvVCmtA%3D%3D 12147651 (Pubitemid 34888301)
7. D Lavergne EM de Villiers 1999 Papillomavirus in esophageal papillomas and carcinomas Int J Cancer 80 681 684 10.1002/(SICI)1097-0215(19990301)80: 5<681::AID-IJC8>;3.0.CO;2-A 10.1002/(SICI)1097-0215(19990301)80:5<681:: AID-IJC8>3.0.CO;2-A 1:STN:280:DyaK1M7ktVeqtw%3D%3D 10048966
8. N Normanno C Bianco A De Luca DS Salomon 2001 The role of EGF-related peptides in tumor growth Front Biosci 6 D685 D707 10.2741/Normano 10.2741/Normano 1:CAS:528:DC%2BD3MXlslKht70%3D 11333208
9. DA Fisher J Lakshmanan 1990 Metabolism and effects of epidermal growth factor and related growth factors in mammals Endocr Rev 11 418 442 10.1210/edrv-11-3-418 1:CAS:528:DyaK3cXmtVCrur8%3D 2226349
10. LC Groenen EC Nice AW Burgess 1994 Structure-function relationships for the EGF/TGF-alpha family of mitogens Growth Factors 11 235 257 10.3109/08977199409010997 10.3109/08977199409010997 1:STN:280: DyaK2M3pvVensw%3D%3D 7779404
11. LS Wang KC Chow KH Chi CC Liu WY Li JH Chiu MH Huang 1999 Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors Am J Gastroenterol 94 1933 1940 10.1111/j.1572-0241.1999. 01233.x 10.1111/j.1572-0241.1999.01233.x 1:STN:280:DyaK1Mzjt1yqtw%3D%3D 10406262 (Pubitemid 29315913)
12. Y Shimada M Imamura G Watanabe S Uchida H Harada T Makino M Kano 1999 Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology Br J Cancer 80 1281 1288 10.1038/sj.bjc.6690499 10.1038/sj.bjc.6690499 1:STN:280:DyaK1MzgtlCkug%3D%3D 10376985
13. Y Kitagawa M Ueda N Ando S Ozawa N Shimizu M Kitajima 1996 Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma Clin Cancer Res 2 909 914 1:STN:280:DyaK1M%2FjsFSqtQ%3D%3D 9816249
14. K Iihara H Shiozaki H Tahara K Kobayashi M Inoue S Tamura M Miyata H Oka Y Doki T Mori 1993 Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma. Implication for the autocrine proliferation Cancer 71 2902 2909 10.1002/1097-0142(19930515)71:10<2902::AID- CNCR2820711004>3.0.CO;2-J 10.1002/1097-0142(19930515)71:10<2902::AID- CNCR2820711004>3.0.CO;2-J 1:STN:280:DyaK3s3lvVKhtg%3D%3D 8490817
15. S Ozawa M Ueda N Ando O Abe N Shimizu 1987 High incidence of EGF receptor hyperproduction in esophageal squamous-cell carcinomas Int J Cancer 39 333 337 10.1002/ijc.2910390311 10.1002/ijc.2910390311 1:CAS:528:DyaL2sXitFWrs78%3D 3493224 (Pubitemid 17044402)
16. F Hara M Aoe H Doihara N Taira T Shien H Takahashi S Yoshitomi K Tsukuda S Toyooka T Ohta N Shimizu 2005 Antitumor effect of Gefitinib ('Iressa') on esophageal squamous cell carcinoma cell lines in vitro and in vivo Cancer Lett 226 37 47 10.1016/j.canlet.2004.12.025 10.1016/j.canlet.2004.12.025 1:CAS:528:DC%2BD2MXlvFeitLc%3D 16004931 (Pubitemid 40943428)
17. F Teraishi S Kagawa T Watanabe Y Tango T Kawashima T Umeoka M Nisizaki N Tanaka T Fujiwara 2005 ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of trail in human esophageal squamous cell carcinoma FEBS Lett 579 4069 4075 10.1016/j.febslet.2005.06.031 10.1016/j.febslet.2005.06.031 1:CAS:528: DC%2BD2MXmvVChurY%3D 16023108 (Pubitemid 41021792)
18. M Shahbazi V Pravica N Nasreen H Fakhoury AA Fryer RC Strange PE Hutchinson JE Osborne JT Lear AG Smith IV Hutchinson 2002 Association between functional polymorphism in EGF gene and malignant melanoma Lancet 359 397 401 10.1016/S0140-6736(02)07600-6 10.1016/S0140-6736(02)07600-6 1:CAS:528: DC%2BD38XhtFyrs7g%3D 11844511 (Pubitemid 34158948)
19. SL McCarron AC Bateman JM Theaker WM Howell 2003 EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma Int J Cancer 107 673 675 10.1002/ijc.11448 10.1002/ijc.11448 1:CAS:528:DC%2BD3sXoslCjs7o%3D 14520709 (Pubitemid 37296132)
20. I Okamoto F Roka J Krogler G Endler S Kaufmann S Tockner C Marsik B Jilma C Mannhalter O Wagner H Pehamberger 2006 The EGF A61 G polymorphism is associated with disease-free period and survival in malignant melanoma J Invest Dermatol 126 2242 2246 10.1038/sj.jid.5700377 10.1038/sj.jid.5700377 1:CAS:528:DC%2BD28Xps1aisb4%3D 16691190 (Pubitemid 44413171)
21. Y Hamai S Matsumura K Matsusaki Y Kitadai K Yoshida Y Yamaguchi K Imai K Nakachi T Toge W Yasui 2005 A single nucleotide polymorphism in the 5′ untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer Pathobiology 72 133 138 10.1159/000084116 10.1159/000084116 1:CAS:528:DC%2BD2MXjslertLs%3D 15860930 (Pubitemid 40674996)
22. G Jin R Miao Y Deng Z Hu Y Zhou Y Tan J Wang Z Hua W Ding L Wang W Chen J Shen X Wang Y Xu H Shen 2007 Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population Cancer Sci 98 864 868 10.1111/j.1349-7006.2007.00463.x 10.1111/j.1349-7006.2007.00463.x 1:CAS:528:DC%2BD2sXmsVWmt7c%3D 17433039 (Pubitemid 46691824)
23. S Kang JW Kim NH Park YS Song SY Park SB Kang HP Lee 2007 Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer Int J Gynecol Cancer 17 492 496 10.1111/j.1525-1438.2007.00870.x 10.1111/j.1525-1438.2007. 00870.x 1:STN:280:DC%2BD2s7mtFSgsA%3D%3D 17316357 (Pubitemid 46426784)
24. YJ Lim JW Kim JY Song MS Hong SY Jin SH Yoon HJ Park BK Choe JJ Lee SV Yim SI Hong HH Baik E Ha YH Park 2005 Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population Neurosci Lett 374 157 160 10.1016/j.neulet.2004.10.055 10.1016/j.neulet.2004. 10.055 1:CAS:528:DC%2BD2MXkvFKlsg%3D%3D 15663953 (Pubitemid 40128286)
25. DA Bhowmick Z Zhuang SD Wait RJ Weil 2004 A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease Cancer Res 64 1220 1223 10.1158/0008-5472.CAN-03-3137 10.1158/0008-5472.CAN-03-3137 1:CAS:528: DC%2BD2cXhtleisLs%3D 14973082 (Pubitemid 38235584)
26. BM Costa P Ferreira S Costa P Canedo P Oliveira A Silva F Pardal G Suriano JC Machado JM Lopes RM Reis 2007 Association between functional EGF +61 polymorphism and glioma risk Clin Cancer Res 13 2621 2626 10.1158/1078-0432.CCR- 06-2606 10.1158/1078-0432.CCR-06-2606 1:CAS:528:DC%2BD2sXkslOhtbw%3D 17473192 (Pubitemid 46788028)
27. KK Tanabe A Lemoine DM Finkelstein H Kawasaki T Fujii RT Chung GY Lauwers Y Kulu A Muzikansky D Kuruppu M Lanuti JM Goodwin D Azoulay BC Fuchs 2008 Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis JAMA 299 53 60 10.1001/jama.2007.65 10.1001/jama.2007.65 1:CAS:528:DC%2BD1cXitFOmtQ%3D%3D 18167406
28. KL Spindler JN Nielsen D Ornskov I Brandslund A Jakobsen 2007 Epidermal growth factor (EGF) A61 G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer Acta Oncol 46 1113 1117 10.1080/02841860701338853 10.1080/02841860701338853 1:CAS:528:DC%2BD2sXht1GrsrnL 17851837 (Pubitemid 350058877)
29. AL Teixeira R Ribeiro D Cardoso D Pinto F Lobo A Fraga F Pina F Calais-da-Silva R Medeiros 2008 Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients Clin Cancer Res 14 3367 3371 10.1158/1078-0432.CCR-07- 5119 10.1158/1078-0432.CCR-07-5119 1:CAS:528:DC%2BD1cXmslygsLY%3D 18519765
30. M Lanuti G Liu JM Goodwin R Zhai BC Fuchs K Asomaning L Su NS Nishioka KK Tanabe DC Christiani 2008 A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome Clin Cancer Res 14 3216 3222 10.1158/1078-0432.CCR-07-4932 10.1158/1078-0432. CCR-07-4932 1:CAS:528:DC%2BD1cXmtVCmu7w%3D 18483390
31. M Jain S Kumar R Upadhyay P Lal A Tiwari UC Ghoshal B Mittal 2007 Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFr) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer Cancer Biol Ther 6 1553 1558 1:CAS:528:DC%2BD1cXjslWls7k%3D 17912028
32. LB Gao YS Wei B Zhou YY Wang WB Liang C Li Y Li P Bai WL Fang H Xue L Zhang 2008 No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma Cancer Genet Cytogenet 185 69 73 10.1016/j.cancergencyto.2008.04.019 10.1016/j.cancergencyto. 2008.04.019 1:CAS:528:DC%2BD1cXhtVamtLnL 18722874
33. Inagaki M, Yoshida S, Kennedy S, Takemura N, Deguchi M, Ohara N, Maruo T. Association study between epidermal growth factor receptor and epidermal growth factor polymorphisms and endometriosis in a Japanese population. Gynecol Endocrinol. 2007;23:474-478. (Pubitemid 47575061)
34. S Anttila A Illi O Kampman KM Mattila T Lehtimaki E Leinonen 2004 Association of EGF polymorphism with schizophrenia in Finnish men NeuroReport 15 1215 1218 10.1097/00001756-200405190-00027 10.1097/00001756-200405190-00027 1:CAS:528:DC%2BD2cXjs1Ojsbo%3D 15129177 (Pubitemid 38670084)
35. E Vauleon N Auger A Benouaich-Amiel F Laigle-Donadey G Kaloshi J Lejeune JY Delattre J Thillet M Sanson 2007 The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma Cancer Genet Cytogenet 172 33 37 10.1016/j.cancergencyto.2006.07.013 10.1016/j.cancergencyto.2006.07.013 1:CAS:528:DC%2BD28Xhtlarsr3F 17175377 (Pubitemid 44920265)
36. MR James NK Hayward T Dumenil GW Montgomery NG Martin DL Duffy 2004 Epidermal growth factor gene (EGF) polymorphism and risk of melanocytic neoplasia J Invest Dermatol 123 760 762 10.1111/j.0022-202X.2004.23305.x 10.1111/j.0022-202X.2004.23305.x 1:CAS:528:DC%2BD2cXot1KgsLw%3D 15373782 (Pubitemid 39281618)
37. DS Salomon R Brandt F Ciardiello N Normanno 1995 Epidermal growth factor-related peptides and their receptors in human malignancies Crit Rev Oncol Hematol 19 183 232 10.1016/1040-8428(94)00144-I 10.1016/1040-8428(94)00144-I 1:STN:280:DyaK2Mzjs1KgsQ%3D%3D 7612182
38. RN Jorissen F Walker N Pouliot TP Garrett CW Ward AW Burgess 2003 Epidermal growth factor receptor: mechanisms of activation and signalling Exp Cell Res 284 31 53 10.1016/S0014-4827(02)00098-8 10.1016/S0014-4827(02)00098-8 1:CAS:528:DC%2BD3sXitVyltr0%3D 12648464 (Pubitemid 36331965)
39. CM Stoscheck LE King Jr 1986 Role of epidermal growth factor in carcinogenesis Cancer Res 46 1030 1037 1:CAS:528:DyaL28XhsVKgtro%3D 3002608
40. SE Singletary FL Baker G Spitzer SL Tucker B Tomasovic WA Brock JA Ajani AM Kelly 1987 Biological effect of epidermal growth factor on the in vitro growth of human tumors Cancer Res 47 403 406 1:CAS:528:DyaL2sXps12isg%3D%3D 3491676
41. KL Amend JT Elder LP Tomsho JD Bonner TM Johnson J Schwartz M Berwick SB Gruber 2004 EGF gene polymorphism and the risk of incident primary melanoma Cancer Res 64 2668 2672 10.1158/0008-5472.CAN-03-3855 10.1158/0008-5472.CAN-03- 3855 1:CAS:528:DC%2BD2cXjtV2lt74%3D 15087376 (Pubitemid 38500598)
42. JA Randerson-Moor R Gaut F Turner L Whitaker JH Barrett S Silva Idos A Swerdlow DT Bishop JA Bishop 2004 The relationship between the epidermal growth factor (EGF) 5'UTR variant A61 G and melanoma/nevus susceptibility J Invest Dermatol 123 755 759 10.1111/j.0022-202X.2004.23304.x 10.1111/j.0022-202X.2004. 23304.x 1:CAS:528:DC%2BD2cXot1KgsL8%3D 15373781 (Pubitemid 39281617)
43. HG Kang JE Choi WK Lee S Kam SI Cha CH Kim TH Jung JY Park 2007 +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer Respirology 12 902 905 10.1111/j.1440-1843.2007.01152.x 10.1111/j.1440-1843. 2007.01152.x 17986122 (Pubitemid 350045717)
44. Y Goto T Ando H Goto N Hamajima 2005 No association between EGF gene polymorphism and gastric cancer Cancer Epidemiol Biomarkers Prev 14 2454 2456 10.1158/1055-9965.EPI-05-0401 10.1158/1055-9965.EPI-05-0401 1:CAS:528: DC%2BD2MXhtVymt7jJ 16214932 (Pubitemid 41437852)